Results 281 to 290 of about 2,285,924 (374)

Restoration of Autophagy and Apoptosis in Myelodysplastic Syndromes: The Effect of Azacitidine in Disease Pathogenesis. [PDF]

Curr Issues Mol Biol
Tsekoura G, Agathangelidis A, Kontandreopoulou CN, Fasouli ES, Katsantoni E, Pliaka V, Alexopoulos L, Katana E, Papaioannou M, Taktikou G, Strataki ME, Taliouraki A, Mantzourani M, Viniou NA, Diamantopoulos PT, Kollia P.   +15 more
europepmc   +1 more source

Research Communication: Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 9, Page 939-943, November 2025.
Clinically relevant endoscopic findings in asymptomatic Fanconi Anemia patients. ABSTRACT Fanconi anaemia (FA), a rare genetic disorder of DNA repair, predisposes to squamous cell carcinomas of head, neck and oesophagus. We assessed the value of screening esophagogastroduodenoscopy (EGD) in 20 asymptomatic adults (median age 23.5, 65% female) with FA ...
Joshua A. Sloan, Nicha Wongjarupong, Vikram Christian, Nabeel Azeem, Kevin O. Turner, C. Prakash Gyawali, Margaret L. MacMillan, John E. Wagner   +7 more
wiley   +1 more source

Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in Denmark

European Journal of Haematology, Volume 115, Issue 5, Page 474-483, November 2025.
ABSTRACT Objective Patients with polycythaemia vera (PV) may experience symptoms and cardiovascular complications before receiving a diagnosis. Understanding the associated patterns of healthcare and drug utilisation may help detect patients who need diagnostic workup.
Karoline Mathilde Lundgaard, Dustin Andersen Patel, Mette Brabrand, Christen Lykkegaard Andersen, Anton Pottegård   +4 more
wiley   +1 more source

Impact of Pre-Treatment Serum Ferritin on Response and Survival in Myelodysplastic Syndromes Treated With Azacytidine: A Multivariate Analysis. [PDF]

Cancer Med
Carrasco GM, Flores RMO, Delgado RG, Morcillo BC, Rosell Mas AI, Díaz Canales D, González MR, Gomariz MC, Escamilla-Sánchez A.   +8 more
europepmc   +1 more source

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

The Lancet Oncology, 2009
P. Fenaux, G. Mufti, E. Hellstrom-Lindberg, V. Santini, C. Finelli, A. Giagounidis, R. Schoch, N. Gattermann, G. Sanz, A. List, S. Gore, J. Seymour, J. Bennett, J. Byrd, J. Backstrom, L. Zimmerman, D. McKenzie, C. Beach, L. Silverman   +18 more
semanticscholar   +1 more source

Risk of second primary malignancies after adjuvant chemotherapy for colon cancer

Cancer, Volume 131, Issue 20, 15 October 2025.
Abstract Background Advances in adjuvant chemotherapy have improved survival in patients with stage II–III colon cancer (CC). However, concerns have emerged regarding the risk of second and subsequent primary malignancies (SPMs) based on preclinical data and registry‐based studies.
Tomas Buchler, Monika Ambrozova, Ondrej Majek, Tereza Dianova, Petr Klika, Ladislav Dusek   +5 more
wiley   +1 more source

Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromes. [PDF]

Front Med (Lausanne)
Hausman R, Gat R, Goldschmidt N, Mittelman M, Oster HS.   +4 more
europepmc   +1 more source

Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes

, 1999
Masanobu Kitagawa, Makoto Takahashi, S Yamaguchi, M. Inoue, Satoshi Ogawa, K. Hirokawa, Ryuichi Kamiyama   +6 more
openalex   +1 more source

5‐fluoro‐deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long‐term outcomes in soft tissue sarcomas: Results from a prospective trial

Cancer, Volume 131, Issue 20, 15 October 2025.
Abstract Background Only 30%–40% of high‐grade sarcomas respond to initial chemotherapy, which can have significant toxicities. Computed tomography imaging alone has limitations in evaluating treatment response. Imaging with 5‐fluoro‐deoxyglucose–positron emission tomography/computed tomography (FDG‐PET/CT), which evaluates tumor metabolism, offers an ...
Edward Y. Cheng, Andrea P. Espejo Freire, Juan C. Manivel, Jerry W. Froelich, Brenda J. Weigel, Denis R. Clohisy, Christian M. Ogilvie, Rich Evans, L. Chinsoo Cho, Kathryn E. Dusenbery, Keith M. Skubitz   +10 more
wiley   +1 more source

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis. [PDF]

Ann Hematol
Rauhe KA, Kasprzak A, Schulz F, Nachtkamp K, Strupp C, Kündgen A, Dietrich S, Mayer K, Götze KS, Hofmann WK, Giagounidis A, Gattermann N, Germing U.   +12 more
europepmc   +1 more source